Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis-Reference-Cited by-同舟云学术

Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis

Published:2009-01-15 Issue:2 Volume:57 Page:182-193
ISSN:0894-1491
Container-title:Glia
language:en
Short-container-title:Glia

Author:

Paintlia Ajaib S.,Paintlia Manjeet K.,Singh Inderjit,Skoff Robert B.,Singh Avtar K.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Neurology

Reference65 articles.

1. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17;Aggarwal;J Biol Chem,2003

2. Interferon beta-1b treatment in patients with relapsing-remitting multiple sclerosis under a standardized protocol in Spain;Arbizu;Acta Neurol Scand,2000

3. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS;Arnett;Science,2004

4. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion;Barnett;Ann Neurol,2004

5. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors;Besser;J Immunol,1999

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effect of pitavastatin on motor deficit and functional recovery in sciatic nerve injury: A CatWalk study;Turkish Journal of Physical Medicine and Rehabilitation;2023-08-07

2. Rehabilitation treatment of multiple sclerosis;Frontiers in Immunology;2023-04-06

3. The Effects of PDE Inhibitors on Multiple Sclerosis: a Review of in vitro and in vivo Models;Current Pharmaceutical Design;2021-08-04

4. Compartmentalized Signaling in Aging and Neurodegeneration;Cells;2021-02-22

5. Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis;Frontiers in Immunology;2021-02-15